We are live on
!
Find out more
QC
Quadrature Capital Portfolio holdings
AUM
$11.7B
1-Year Est. Return
87.29%
This Fund
S&P 500
This Quarter
Est. Return
-2.54%
1 Year Est. Return
+87.29%
3 Year Est. Return
+211.84%
5 Year Est. Return
+162.22%
10 Year Est. Return
+656.25%
AUM
$4.51B
AUM Growth
-$481M
(-9.6%)
Cap. Flow
-$244M
Cap. Flow
% of AUM
-5.41%
Top 10 Holdings %
Top 10 Hldgs %
25.07%
Holding
1,566
New
582
Increased
206
Reduced
242
Closed
534
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$243M |
| 2 |
Canadian National Railway
CNI
|
+$116M |
| 3 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$99M |
| 4 |
Stellantis
STLA
|
+$87.2M |
| 5 |
Canadian Natural Resources
CNQ
|
+$75.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$182M |
| 2 |
Tesla
TSLA
|
+$165M |
| 3 |
Ferrari
RACE
|
+$145M |
| 4 |
Elevance Health
ELV
|
+$118M |
| 5 |
UnitedHealth
UNH
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.4% |
| 2 | Financials | 12.65% |
| 3 | Industrials | 10.78% |
| 4 | Communication Services | 8.14% |
| 5 | Consumer Discretionary | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
RLX Technology
RLX
$2.44B
| $50.6K | ﹤0.01% |
+26,838
| New | +$59.5K |
|
977
Prime Medicine
PRME
$571M
| $49.6K | ﹤0.01% |
+24,802
| New | +$63.3K |
|
978
Allogene Therapeutics
ALLO
$725M
| $49.5K | ﹤0.01% |
+33,991
| New | +$64.1K |
|
|
DCH
979
Dauch Corp
DCH
$1.58B
| $49K | ﹤0.01% |
12,032
-16,114
| -57% | -$82.7K |
|
980
Immunic
IMUX
$192M
| $48.1K | ﹤0.01% |
+4,454
| New | +$48.1K |
|
981
GoodRx Holdings
GDRX
$1.25B
| $46K | ﹤0.01% |
+10,428
| New | +$48.9K |
|
982
Amylyx Pharmaceuticals
AMLX
$2.53B
| $45K | ﹤0.01% |
+12,744
| New | +$45.4K |
|
983
James River Group Holdings
JRVR
$210M
| $44.8K | ﹤0.01% |
10,650
-7,599
| -42% | -$34.5K |
|
|
MODV
984
DELISTED
ModivCare
MODV
| $44.8K | ﹤0.01% |
+34,038
| New | +$165K |
|
985
Rimini Street
RMNI
$458M
| $43.9K | ﹤0.01% |
12,584
-18,457
| -59% | -$59.8K |
|
986
Codexis
CDXS
$161M
| $41.7K | ﹤0.01% |
+15,399
| New | +$59.7K |
|
|
REE
987
DELISTED
REE Automotive
REE
| $40.3K | ﹤0.01% |
+15,325
| New | +$110K |
|
988
Dakota Gold
DC
$821M
| $40.1K | ﹤0.01% |
+15,196
| New | +$41.7K |
|
989
Magnachip Semiconductor
MX
$134M
| $39.4K | ﹤0.01% |
11,460
-20,636
| -64% | -$86.9K |
|
|
HOUS
990
DELISTED
Anywhere Real Estate
HOUS
| $38.8K | ﹤0.01% |
11,657
-22,301
| -66% | -$79K |
|
991
Gain Therapeutics
GANX
$75.5M
| $38.3K | ﹤0.01% |
+20,154
| New | +$44.7K |
|
|
BSIN
992
Big Sky Industrial
BSIN
$63.3M
| $38.1K | ﹤0.01% |
+31,769
| New | +$60.1K |
|
993
American Battery Technology Co
ABAT
$361M
| $37.7K | ﹤0.01% |
+37,151
| New | +$50.4K |
|
994
Solid Power
SLDP
$536M
| $37.1K | ﹤0.01% |
+35,714
| New | +$48.9K |
|
995
Puma Biotechnology
PBYI
$442M
| $37K | ﹤0.01% |
+12,508
| New | +$39.2K |
|
|
RVPH
996
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $36.9K | ﹤0.01% |
+1,947
| New | +$61.2K |
|
997
Cardlytics
CDLX
$22.4M
| $36.3K | ﹤0.01% |
1,995
+326
| +20% | +$9.31K |
|
998
Rezolute
RZLT
$451M
| $36.1K | ﹤0.01% |
+12,439
| New | +$54.2K |
|
999
OraSure Technologies
OSUR
$275M
| $35.9K | ﹤0.01% |
+10,609
| New | +$39.1K |
|
1000
Smart Sand
SND
$197M
| $35.7K | ﹤0.01% |
+13,783
| New | +$32.4K |
|
Similar funds
BCI
VA
PI
UE
LC
DWM
ERSOT
Quadrature Capital's Q1 2025 Portfolio in Review
As of Q1 2025, Quadrature Capital held 1,566 positions worth $4.51B, down 9.6% from $4.99B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Quadrature Capital withdrew a net $244M in Q1 2025, closing 534 positions and reducing 242 holdings. Its most notable exit was NVIDIA, an estimated $182M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.
Against the trend, Quadrature Capital opened a new position in Stellantis worth $75.4M.
- Quadrature Capital's largest Q1 2025 buy was Stellantis: 6,785,857 shares worth $75.4M.
- Quadrature Capital added most to Broadcom in Q1 2025, an estimated $243M increase.
- Quadrature Capital's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $111M.
- Quadrature Capital fully exited NVIDIA in Q1 2025, selling an estimated $182M.
- Quadrature Capital's ten largest holdings make up 25% of its $4.51B portfolio in Q1 2025.
- Quadrature Capital opened 582 new positions and closed 534 in Q1 2025.
- Quadrature Capital's portfolio value fell 9.6% quarter-over-quarter to $4.51B.
Based on Quadrature Capital's 13F filing for Q1 2025, filed 13 May 2025.